According to Arjun Handa, Vice-Chairman MD of Claris Lifesciences Ltd, Budget has given a good road map of not just the next year but also for the tenure of the government, implementation of long awaited GST and bringing the corporate tax rate to 25 percent ... Money Control, 5 days ago
2 images for "claris lifesciences"
Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'
(GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/3fs8dg/the_generic_drugs ) has announced the addition of SNS Research's new report "The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & ...RCL Advisors, 3 days ago Generic Drugs Market Analysis to 2030 With Strategies of 130 Companies Including Generic and Innovator Drug Manufacturers Tamar Securities, 1 week ago The Generic Drugs Market: 2015 2030 - Opportunities, Challenges, Strategies & Forecasts Research and Markets, 2 weeks ago Global Generic Drugs Market to Grow at 12% CAGR by 2020 Forecast a New Research Report at ReportsnReports.com Wall Street Business Network, 2 weeks ago
Transplantation is the procedure in which diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore the normal functions of the body. Organs such as kidneys, liver, heart, lungs, intestine, ...Financial Content, 1 week ago Global Transplantation Market 2015-2019 Review Seeker, 1 week ago Global Transplantation Market Will Hit at CAGR of 9.36% Growth Up to 2019. Digital Journal, 1 week ago
Rising Popularity of Home Based Infusion Nutrition Therapy Drives the Global Parenteral Nutrition Market, According to a New Report by Global Industry Analysts, Inc.
PRWeb Follow us on LinkedIn - Parenteral nutrition refers to feeding patients through the intravenous route, bypassing the normal route of feeding. Parenteral nutrition is administered to patients with a dysfunctional gastrointestinal system. The ...Franklin Credit Management Corporation, 1 week ago
The global market for Clinical Nutrition Products is projected to reach US$53.9 billion by 2020, driven by specific nutritional needs of the elderly. Clinical nutrition is critical for patients who are unable to consume normal food, as nutritional ...TransWorldNews, 1 week ago Aging Population & Rising Prevalence of Chronic Illnesses Drive the Clinical Nutrition Products Market, According to a New Report by Global Industry Analysts, Inc. EMoneyDaily, 1 month ago
Claris Lifesciences shares hit 52-week high on strong financial performance in the fourth quarter of calendar year 2014. The company's consolidated net profit for the quarter jumped 340 per cent on year-on-year basis to Rs 90 crore from Rs 20.4 ...Hindu Business Line, 3 weeks ago Claris Life hits record high on strong Q4 results Business Standard India, 3 weeks ago
Sales rise 24.04% to Rs 179.15 crore Net profit of Claris Lifesciences rose 406.20% to Rs 89.85 crore in the quarter ended December 2014 as against Rs 17.75 crore during the previous quarter ended December 2013. Sales rose 24.04% to Rs 179.15 crore ...Business Standard India, 3 weeks ago Claris Lifesciences standalone net profit rises 317.36% in the December 2014 quarter Business Standard, 3 weeks ago
Shares of Claris Lifesciences surged 20 per cent amid reports that big national and international companies are in the fray to buy company's injectible business. The stock zoomed 19.96 per cent to Rs 248.20 -- its upper circuit limit on the ...Business Standard, 3 weeks ago Claris surges 18% as pharma cos in race to buy injectible biz Economic Times, 3 weeks ago
Email this Print Related to : Claris Lifesciences Ltd Claris Lifesciences Ltd BSE 12 Feb 15 | 12:40 PM 248.20 41.3 (19.96%) NSE 01 Jan 70 | 05:30 AM 0.00 0 (0%) Shares of Claris Lifesciences is locked in upper circuit of 20% ...Smart Investor, 3 weeks ago Claris Lifesciences denies talks to sell injectables arm Yahoo! Maktoob News, 3 weeks ago India's Claris Lifesciences denies talks to sell injectables arm Sify, 3 weeks ago Claris Lifesciences to hold board meeting Business Standard, 4 weeks ago
EBITDA grew by 95 per cent Claris Lifesciences announced its quarterly un-audited financial results for the quarter ended December 31, 2014 at its board meeting held at its registered office in Ahmedabad. The key financial highlights of the ...Financial Express, 2 weeks ago Claris Lifesciences Q4 PAT jumps 404% India Infoline, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!